← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jun 1, 2000
GP-Pharm— Founded
2010s
- Aug 28, 2018
leuprolide— NDA Secondary Org
Drugs by trial phase (1 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (1)
Recent trials (3)
- NCT01415960Lead sponsorPhase 3Sep 1, 2011
- NCT00630799Lead sponsorPhase 3May 1, 2008
- NCT00128531Lead sponsorPhase 3Sep 1, 2005
Details
- Founded
- Barcelona, ES Jun 1, 2000
- Last known activity
- Sep 1, 2011